Single-chain lipopeptide vaccines for the induction of virus-specific cytotoxic T cell responses in randomly selected populations

Molecular Immunology

Volumn 38, Issue 6, 2001, Pages 423-431

  Gras Masse, Hélène ^a  

^a INSTITUT DE BIOLOGIE DE LILLE   (France)

Author keywords

CTL introduction; Lipopeptide; Synthetic vaccine

Indexed keywords

AMINO ACID DERIVATIVE; CD8 ANTIGEN; DECANOIC ACID DERIVATIVE; EPITOPE; GAMMA INTERFERON RECEPTOR; GLYCOPROTEIN GP 160; HLA A2 ANTIGEN; IMMUNOLOGICAL ADJUVANT; LIPOPEPTIDE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; NEUTRALIZING ANTIBODY; PIMELAUTIDE; PROTEIN KINASE C; TABILAUTIDE; VACCINE; VIRUS PROTEIN;

AMINO ACID SEQUENCE; ANTIGEN PRESENTING CELL; CELL MEMBRANE PERMEABILITY; CELL SUBPOPULATION; CHEMICAL MODIFICATION; CLINICAL TRIAL; CYTOTOXIC T LYMPHOCYTE; DRUG FORMULATION; DRUG MECHANISM; ENZYME SUBSTRATE; HELPER CELL; HUMAN; IMMUNE RESPONSE; IMMUNOGENICITY; LYMPHOCYTE ACTIVATION; MOLECULAR DYNAMICS; NONHUMAN; PEPTIDE SYNTHESIS; PRIORITY JOURNAL; REVIEW; VACCINE PRODUCTION;

ANTIGENS, VIRAL; HUMANS; LIPOPROTEINS; PEPTIDES; T-LYMPHOCYTES; T-LYMPHOCYTES, CYTOTOXIC; VACCINES, SUBUNIT; VIRUS DISEASES;

EID: 0035652261     PISSN: 01615890     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0161-5890(01)00078-5     Document Type: Review

References (44)

1. Lipopeptide presentation pathway in dendritic cells
2. Priming for virus-specific CD8+ but not CD4+ cytotoxic T lymphocytes with synthetic lipopeptide is influenced by acylation units and liposome encapsulation
3. Muramylpeptides and lipopeptides: Studies towards immunostimulants (tetrahedron report number 62)
4. Lipopeptide immunization without adjuvant induces potent and long-lasting B, Th and CTL responses against a malaria liver stage antigen in mice and chimpanzee(s)
5. Synthesis of conjugates between luteinising releasing hormome (LH-RH) and N-acetyl-muramyl-L-alanyl-D-isoglutamine (MDP): Models of totally synthetic vaccines
6. A novel lipophilic glyoxylic acid derivative for the lipidation of peptides using salt-free hydrazone ligation
7. Chemoselective acylation of fully deprotected hydrazino acetyl peptides. Application to the synthesis of lipopeptides
8. Synthesis by chemoselective ligation and biological evaluation of novel cell-permeable PKC-ζ pseudosubstrate lipopeptides
9. Lipidation of a multi-epitope peptide cocktail by chemoselective hydrazone formation
10. Positive role of macaque cytotoxic T lymphocytes during SIV infection: Decrease of cellular viremia and increase of asymptomatic clinical period
11. Immunization of mice with lipopeptide antigens encapsulated in novel liposomes prepared from the polar lipids of various Archaeobacteria elicits rapid and prolonged specific protective immunity against infection with the facultative intracellular pathogen, listeria monocytogenes
12. Protection against plasmodium falciparum malaria in chimpanzees by immunization with the conserved pre-erythrocytic liver-stage antigen 3
13. Pimelautide or trimexautide as built-in adjuvants associated to an HIV-1-derived peptide: Synthesis and in vivo induction of antibody andvirus-specific cytotoxic T lymphocyte mediated response
14. Comparative efficiency of simple lipopeptide constructs for in vivo induction of virus-specific CTL
15. In vivo priming of virus-specific cytotoxic T lymphocytes with synthetic lipopeptide vaccine
16. A myristoylated pseudosubtrate peptide: A novel PKC inhibitor
17. Multiepitopic B and T cell responses induced in humans by a human immunodeficiency virus type 1
18. Microbial peptides stimulate dendritic cell maturation via toll like receptor 2
19. Endocytosis of an HIV-1-derived lipopeptide into human dendritic cells followed by class I-restrcted CD8+ T lymphocyte activation
20. Utilization of MHC class I transgenic mice for development of minigene DNA vaccines encoding multiple HLA-restricted CTL epitopes
21. Characterization of a multi-lipopeptides mixture used as an HIV-1 vaccine candidate
22. Assessing cytoplasm delivery of lipopeptides into intact cells by a functional assay based on PKC inhibition. I. The Jurkat Model
23. Modification of an HLA-A*0201-retricted minimal cytotoxic epitope by an additionnal palmitoyl-lysine residue increases the life span of functionnal presentation to wild-type specific cytotoxic T cells
24. Synthetic peptides coupled to the lipotripeptide P3CSS induce in vivo B and T helper cell responses to HIV-1 reverse transcriptase
25. Lipopeptides containing 2-(palmitoylamino)-6,7-bis(palmitoyloxy)heptanoic acid: Syntheis, stereospecific stimulation of B lymphocytes and macrophages, and adjuvanticity in vivo and in vitro
26. Selection of virus variants and emergence of virus-escape mutants after immunization with an epitope vaccine
27. Type 1 CD4+ T cell help is required for induction of anti-peptide multispecific cytotoxic T lymphocytes by a lipopeptidic vaccine in Rhesus Macaques
28. Temporal loss of Nef-epitope recognition following macaque lipopeptide immunization and SIV challenge
29. Hepatitis B virus surface antigen (HBVsAg) as carrier for synthetic peptides having an attached hydrophobic tail
30. Pools of lipidated HTL-CTL constructs prime for pultiple HBV and HCV CTL epitope responses
31. Immunogenicity of foour plasmodium falciparum preerythocytic antigens in Aotus lemurinus monkeys
32. Lipopeptides induce cell-mediated anti-HIV immune responses in seronegative volunteers
33. Long-lasting anti-viral cytotoxic T lymphocytes induced in vivo with chimeric-multirestricted lipopeptides
34. Antigen organization regulates cluster formation and induction of cytotoxic T lymphocytes by helper T cell subsets
35. Binding of IFN-γ and its C-terminal peptide to a cytoplasmic domain of its receptor that is essential for function
36. Identification of IFN-γ receptor binding sites for JAK2 and enhancement o binding by IFN-γ and its C-terminal peptide IFN-γ (95-133)
37. Induction of apoptosis by protein kinase C pseudosubstrate lipopeptides in several human CELLS
38. Unrestricted agonist activity on murine and human cells of a lipopeptide derived from IFN-γ
39. Direct evidence of cytoplasmic delivery of PKC-α, ε and ζ pseudosubstrate lipopeptides: Study of their implication in the induction of apoptosis
40. IFN-γ-derived lipopeptides: Influence of the lipid modification on the conformation and on the ability to induce MHC class II expression in murine and human cells
41. Lipopeptide particles as the immunologically active component of CTL inducing vaccines
42. Development of a lipopeptide-based therapeutic vaccine to treat chronic HBV infection. I. Induction of a primary cytotoxic T lymphocyte response in humans
43. Solid phase peptide synthesis of lipopeptide vaccines eliciting epitope-specific B, T helper and T killer cell response (review)